AT Bancorp reduced its stake in shares of Morgan Stanley (NYSE:MS) by 76.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,798 shares of the financial services provider’s stock after selling 143,303 shares during the period. AT Bancorp’s holdings in Morgan Stanley were worth $1,436,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of MS. FineMark National Bank & Trust increased its position in Morgan Stanley by 2.0% in the second quarter. FineMark National Bank & Trust now owns 4,332 shares of the financial services provider’s stock worth $113,000 after buying an additional 84 shares during the period. Assetmark Inc. boosted its stake in shares of Morgan Stanley by 291.1% in the second quarter. Assetmark Inc. now owns 5,323 shares of the financial services provider’s stock worth $138,000 after buying an additional 3,962 shares in the last quarter. Synovus Financial Corp boosted its stake in shares of Morgan Stanley by 11.3% in the second quarter. Synovus Financial Corp now owns 5,418 shares of the financial services provider’s stock worth $141,000 after buying an additional 549 shares in the last quarter. Acrospire Investment Management LLC boosted its stake in shares of Morgan Stanley by 100.0% in the second quarter. Acrospire Investment Management LLC now owns 6,200 shares of the financial services provider’s stock worth $161,000 after buying an additional 3,100 shares in the last quarter. Finally, Handelsbanken Fonder AB bought a new stake in shares of Morgan Stanley during the second quarter worth about $205,000. Institutional investors and hedge funds own 83.90% of the company’s stock.

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Shares of Morgan Stanley (NYSE:MS) traded up 0.40% during trading on Tuesday, hitting $40.60. The stock had a trading volume of 8,602,864 shares. Morgan Stanley has a 52 week low of $21.16 and a 52 week high of $41.20. The company has a market capitalization of $76.04 billion, a PE ratio of 16.32 and a beta of 1.87. The firm has a 50-day moving average price of $35.45 and a 200 day moving average price of $30.45.

Morgan Stanley (NYSE:MS) last released its quarterly earnings data on Wednesday, October 19th. The financial services provider reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.17. Morgan Stanley had a return on equity of 7.57% and a net margin of 14.44%. The company had revenue of $8.91 billion for the quarter, compared to analyst estimates of $8.17 billion. During the same period in the previous year, the company posted $0.34 EPS. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. Equities analysts anticipate that Morgan Stanley will post $2.71 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 31st were paid a $0.20 dividend. The ex-dividend date was Thursday, October 27th. This represents a $0.80 dividend on an annualized basis and a yield of 1.97%. Morgan Stanley’s dividend payout ratio is currently 32.00%.

COPYRIGHT VIOLATION NOTICE: “Morgan Stanley (MS) Shares Sold by AT Bancorp” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark law. The legal version of this piece can be read at http://www.dailypolitical.com/2016/11/29/morgan-stanley-ms-shares-sold-by-at-bancorp.html.

MS has been the topic of a number of analyst reports. Vetr cut Morgan Stanley from a “sell” rating to a “strong sell” rating and set a $26.38 price objective on the stock. in a research note on Monday, August 15th. Argus upped their price objective on Morgan Stanley from $32.00 to $36.00 and gave the stock a “buy” rating in a research note on Wednesday, August 17th. Buckingham Research upgraded Morgan Stanley from a “neutral” rating to a “buy” rating in a research note on Thursday, August 25th. JPMorgan Chase & Co. set a $32.00 price objective on Morgan Stanley and gave the stock a “buy” rating in a research note on Thursday, September 22nd. Finally, Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $36.00 price objective on the stock in a research note on Wednesday, October 5th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and fifteen have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $32.59.

In other Morgan Stanley news, COO James A. Rosenthal sold 189,000 shares of the company’s stock in a transaction dated Thursday, October 20th. The stock was sold at an average price of $32.85, for a total value of $6,208,650.00. Following the transaction, the chief operating officer now directly owns 372,034 shares in the company, valued at approximately $12,221,316.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Thomas Colm Kelleher sold 222,712 shares of the company’s stock in a transaction dated Thursday, October 20th. The stock was sold at an average price of $32.90, for a total value of $7,327,224.80. Following the completion of the transaction, the president now owns 863,334 shares in the company, valued at $28,403,688.60. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

About Morgan Stanley

Morgan Stanley is a financial holding company. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals. Its segments include Institutional Securities, Wealth Management and Investment Management.

5 Day Chart for NYSE:MS

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.